Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3450)
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,100
Price
$68.98
Total Value
$144.86K
Shares Held After
529,918
% of Holdings
0.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
918
Price
$69.52
Total Value
$63.82K
Shares Held After
527,818
% of Holdings
0.2%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
38,500
Price
$7.11
Total Value
$273.74K
Shares Held After
4,106,452
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
38,500
Price
$7.11
Total Value
$273.74K
Shares Held After
4,106,452
% of Holdings
0.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
1,381
Price
$61.16
Total Value
$84.46K
Shares Held After
152,228
% of Holdings
0.9%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
5,500
Price
$41.98
Total Value
$230.91K
Shares Held After
18,615
% of Holdings
22.8%
Denali Therapeutics Inc. (DNLI)
Chin Peter Scott — Chief Medical Officer
Shares
1,654
Price
$22.29
Total Value
$36.87K
Shares Held After
204,538
% of Holdings
0.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
1,590
Price
$90.00
Total Value
$143.10K
Shares Held After
1,590
% of Holdings
50.0%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
1,590
Price
$85.00
Total Value
$135.15K
Shares Held After
3,180
% of Holdings
33.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
5,386
Price
$90.00
Total Value
$484.74K
Shares Held After
2,547
% of Holdings
67.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
5,387
Price
$85.00
Total Value
$457.89K
Shares Held After
7,933
% of Holdings
40.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
4,564
Price
$85.00
Total Value
$387.94K
Shares Held After
78,532
% of Holdings
5.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
2,900
Price
$91.27
Total Value
$264.68K
Shares Held After
827,991
% of Holdings
0.3%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
7,100
Price
$90.27
Total Value
$640.92K
Shares Held After
830,891
% of Holdings
0.8%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
18
Price
$79.96
Total Value
$1.44K
Shares Held After
13,427
% of Holdings
0.1%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
759
Price
$79.96
Total Value
$60.69K
Shares Held After
312,230
% of Holdings
0.2%
Disc Medicine, Inc. (IRON)
Bitterman Kevin — Director
Shares
912
Price
$79.96
Total Value
$72.92K
Shares Held After
318,866
% of Holdings
0.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Smither John W — Director
Shares
1,600
Price
$25.32
Total Value
$40.51K
Shares Held After
8,760
% of Holdings
15.4%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
900
Price
$24.35
Total Value
$21.91K
Shares Held After
153,082
% of Holdings
0.6%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
3,745
Price
$24.35
Total Value
$91.19K
Shares Held After
163,854
% of Holdings
2.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
9,705
Price
$26.22
Total Value
$254.50K
Shares Held After
0
% of Holdings
100.0%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
31,500
Price
$103.52
Total Value
$3.26M
Shares Held After
781,709
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$491.69
Total Value
$157.34K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$490.94
Total Value
$569.48K
Shares Held After
324,763
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,514
Price
$490.01
Total Value
$741.87K
Shares Held After
325,923
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,425
Price
$489.12
Total Value
$1.68M
Shares Held After
327,437
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,818
Price
$488.08
Total Value
$1.38M
Shares Held After
330,862
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
223
Price
$486.88
Total Value
$108.57K
Shares Held After
333,680
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$485.85
Total Value
$19.43K
Shares Held After
333,903
% of Holdings
0.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
18,378
Price
$3.67
Total Value
$67.45K
Shares Held After
11,242,531
% of Holdings
0.2%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,175
Price
$43.71
Total Value
$51.36K
Shares Held After
166,025
% of Holdings
0.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
2,477
Price
$42.81
Total Value
$106.03K
Shares Held After
167,200
% of Holdings
1.5%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,100
Price
$43.67
Total Value
$48.04K
Shares Held After
131,160
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
2,154
Price
$42.79
Total Value
$92.17K
Shares Held After
132,260
% of Holdings
1.6%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
2,705
Price
$43.66
Total Value
$118.11K
Shares Held After
133,048
% of Holdings
2.0%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
10,405
Price
$42.89
Total Value
$446.30K
Shares Held After
135,753
% of Holdings
7.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
399
Price
$366.56
Total Value
$146.26K
Shares Held After
1,302,145
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
826
Price
$365.41
Total Value
$301.83K
Shares Held After
1,302,544
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,329
Price
$364.48
Total Value
$484.39K
Shares Held After
1,303,370
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
565
Price
$363.34
Total Value
$205.29K
Shares Held After
1,304,699
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,992
Price
$362.65
Total Value
$722.40K
Shares Held After
1,305,264
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,242
Price
$361.61
Total Value
$449.12K
Shares Held After
1,307,256
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,320
Price
$360.47
Total Value
$836.28K
Shares Held After
1,308,498
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,392
Price
$359.39
Total Value
$1.22M
Shares Held After
1,310,818
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,180
Price
$358.42
Total Value
$1.14M
Shares Held After
1,314,210
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,962
Price
$357.57
Total Value
$1.42M
Shares Held After
1,317,390
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,267
Price
$356.37
Total Value
$1.16M
Shares Held After
1,321,352
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,006
Price
$355.57
Total Value
$713.28K
Shares Held After
1,324,619
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,326,625
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
405
Price
$366.56
Total Value
$148.46K
Shares Held After
1,347,543
% of Holdings
0.0%
Showing 351–400 of 3450 transactions (page 8 of 69)